F2 Vision SCS
SEC CIK 1838409 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | 10% | 1.46M | — | $4.05M | 1 | 2022-05-12 | 2022-05-12 |
Most active insiders at CGEM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $11.93M | — |
| 2 | Michaelson Jennifer | CSO | — | $1.62M |
| 3 | Nichols Weston | 10% | $1.39M | — |
| 4 | AHMED NADIM | Pres, CEO, Dir | — | $518.0K |
| 5 | Jones Jeffrey Alan | Chief Medical Off | — | $178.9K |
| 6 | SUMER JACQUELYN L | CLO | — | $136.7K |
| 7 | Fenton Mary Kay | CFO | — | $59.9K |
F2 Vision SCS made no open-market trades at CGEM in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-16 | 2022-05-12+ | CGEM | Cullinan Therapeutics, Inc. | F2 Vision SCS | 10% | S - Sale | $9.66 | -418.7K | 1.46M | -22% | -$4.05M |
Purchase Sale Sale after option exercise All abbreviations